IRIS
COLOMBO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.633
NA - Nord America 2.163
EU - Europa 1.244
SA - Sud America 1.178
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 8.284
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.063
SG - Singapore 1.640
BR - Brasile 975
CN - Cina 903
SE - Svezia 526
HK - Hong Kong 494
VN - Vietnam 331
RU - Federazione Russa 191
IT - Italia 174
DE - Germania 106
AR - Argentina 81
GB - Regno Unito 63
IN - India 49
EC - Ecuador 42
CA - Canada 41
MX - Messico 40
ID - Indonesia 33
FI - Finlandia 31
BD - Bangladesh 30
IE - Irlanda 25
JP - Giappone 24
PY - Paraguay 23
CO - Colombia 22
TR - Turchia 22
AT - Austria 20
FR - Francia 20
IQ - Iraq 20
PL - Polonia 19
ZA - Sudafrica 17
ES - Italia 14
LT - Lituania 14
NL - Olanda 14
PE - Perù 12
UZ - Uzbekistan 12
PK - Pakistan 11
UA - Ucraina 11
IR - Iran 10
CL - Cile 9
MA - Marocco 9
EG - Egitto 7
TN - Tunisia 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
VE - Venezuela 6
AZ - Azerbaigian 5
KE - Kenya 5
OM - Oman 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
EU - Europa 4
IL - Israele 4
JO - Giordania 4
NP - Nepal 4
BA - Bosnia-Erzegovina 3
KZ - Kazakistan 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
MK - Macedonia 2
PH - Filippine 2
SC - Seychelles 2
SN - Senegal 2
TH - Thailandia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BE - Belgio 1
BG - Bulgaria 1
BM - Bermuda 1
BS - Bahamas 1
CH - Svizzera 1
CR - Costa Rica 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PF - Polinesia Francese 1
PS - Palestinian Territory 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
ZW - Zimbabwe 1
Totale 8.284
Salva come PNG Salva come JPEG
Città #
Dallas 705
Singapore 605
Hong Kong 490
Shanghai 285
Hefei 212
Ashburn 201
Princeton 192
Lawrence 191
Ho Chi Minh City 122
Moscow 106
São Paulo 84
New York 82
Beijing 79
Hanoi 67
Milan 59
Los Angeles 47
Boardman 29
Brasília 26
Brooklyn 26
Belo Horizonte 24
Dublin 24
Helsinki 24
Nuremberg 24
Da Nang 23
Rio de Janeiro 22
Munich 20
Warsaw 17
Chennai 16
Haiphong 16
Porto Alegre 16
Tokyo 16
Denver 15
Houston 15
London 15
Montreal 15
Orem 15
Salvador 15
Guayaquil 14
Rome 14
Johannesburg 13
Quito 13
Santa Clara 13
Biên Hòa 12
Brescia 12
Curitiba 12
Frankfurt am Main 12
Mexico City 12
Tashkent 12
Boston 11
Guangzhou 11
Sorocaba 10
Stockholm 10
The Dalles 10
Ankara 9
Bogotá 9
Guarulhos 9
Hangzhou 9
Poplar 9
São Bernardo do Campo 9
Campinas 8
Chicago 8
Dhaka 8
Lima 8
Manchester 8
Phoenix 8
Recife 8
Uberlândia 8
Vienna 8
Buenos Aires 7
Durham 7
Fortaleza 7
Goiânia 7
Hải Dương 7
Mumbai 7
São Gonçalo 7
Toronto 7
Assago 6
Cabo Frio 6
Caxias do Sul 6
Changsha 6
Istanbul 6
Itaquaquecetuba 6
Marília 6
Montevideo 6
Ninh Bình 6
São Vicente 6
Thái Bình 6
Vancouver 6
Anápolis 5
Atlanta 5
Baku 5
Carapicuíba 5
Ciudad del Este 5
Columbus 5
Erbil 5
Florianópolis 5
Ha Long 5
Hortolândia 5
Itajaí 5
Jakarta 5
Totale 4.445
Salva come PNG Salva come JPEG
Nome #
Prognostic impact of mitral regurgitation changes after TAVI 196
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 106
[New therapeutic options for the treatment of tricuspid regurgitation] 101
[Saphenous vein graft aneurysm: percutaneous exclusion using detachable coils] 97
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 97
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 91
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 80
Right ventricular systolic function in severe tricuspid regurgitation: prognostic relevance of longitudinal strain 80
[Severe coronary artery disease and severely impaired renal function. Focused fluid expansion and ultra-low dose contrast medium administration] 78
A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation 78
12 months outcomes after Bioresorbable Vascular Scaffold implantation in Patients with Acute Coronary Syndromes. Data from the European Multicentre GHOST-EU Extended Registry 71
Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation 69
Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study) 69
A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels 68
[40 Years of coronary angioplasty: success comes from skills and determination!] 68
Accuracy and reproducibility of aortic annular measurements obtained from echocardiographic 3D manual and semi-automated software analyses in patients referred for transcatheter aortic valve implantation: implication for prosthesis size selection 68
A Case of Very Late (3 Years) Transcatheter Heart Valve Thrombosis 68
A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions 66
A new tool for the forgotten valve: a score to predict the risk of surgery 65
A Novel Technique for Prosthetic Valve Retrieval After Transcatheter Aortic Valve Embolization 64
Role of Different Antithrombotic Regimens after Percutaneous Left Atrial Appendage Occlusion: A Large Single Center Experience 64
Diabetes and mortality in patients with COVID-19: Are we missing the link? 63
Impact on Outcome of Different Mechanisms, Baseline Degree and Changes of Mitral Regurgitation in Patients With Aortic Stenosis Who Underwent Transcatheter Aortic Valve Replacement 61
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 61
Anesthetic Management of Cardioband Implantation: Data From a Preliminary Experience and New Insights 60
CT-scan theoretical analysis for aortic cross-clamp and opening after transcatheter aortic valve implantation 59
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 59
Acute heart failure management in a young patient requiring complex left main percutaneous coronary intervention, Impella 2.5 and transcatheter aortic valve implantation 58
Long-term clinical outcomes of patients with rheumatoid arthritis and concomitant coronary artery disease 57
Advances in percutaneous interventional therapies: The tricuspid valve 57
Acute and long-term (2-years) clinical outcomes of the CoreValve 31 mm in large aortic annuli: A multicenter study 55
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 55
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 54
Safety and Efficacy of Polymer-Free Drug-Eluting Stents 52
The hidden interplay between sex and COVID-19 mortality: the role of cardiovascular calcification 51
One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in all-comers population. Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry) 51
Feature tracking and mapping analysis of myocardial response to improved perfusion reserve in patients with refractory angina treated by coronary sinus Reducer implantation: a CMR study 50
Coronary calcium score as a predictor of outcomes in the hypertensive Covid-19 population: results from the Italian (S) Core-Covid-19 Registry 49
Concomitant implantation of Impella® on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. 49
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 49
First in man prolonged pressure-controlled intermittent coronary sinus occlusion to treat refractory left ventricular dysfunction and ischemia with patent epicardial coronary arteries 48
Outcome after percutaneous edge-to-edge mitral repair for functional and degenerative mitral regurgitation: a systematic review and meta-analysis 47
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 47
First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement 47
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 46
Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Chronic Total Occlusion Versus Non-Occlusive Coronary Artery Disease 46
A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention 45
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction 45
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention Through Ipsilateral Collateral Channels: A Multicenter Registry 45
Echocardiographic features of post-transcatheter aortic valve implantation thrombosis and endocarditis 45
The impact of the coronary sinus reducer upon left ventricular function in patients with refractory angina pectoris 45
State of the art: Evolving concepts in the treatment of heavily calcified and undilatable coronary stenoses - From debulking to plaque modification, a 40-year-long journey 44
Young Patient with Advanced Heart Failure No Longer a Candidate for Heart Transplantation after MitraClip® Procedure 43
Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions 43
Transcatheter Aortic Valve Implantation in Patients With Advanced Chronic Kidney Disease 43
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 42
Meta-Analysis of Relation Between Left Ventricular Dysfunction and Outcomes After Transcatheter Mitral Edge-to-Edge Repair 42
Mitraclip therapy and surgical mitral repair in patients with moderate to severe left ventricular failure causing functional mitral regurgitation: a single-centre experience 42
Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry 42
Coronary Sinus Reducer Implantation to Reduce the Ischemic Burden in Refractory Angina 42
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 42
Identification of High-Risk Patients after ST-Segment-Elevation Myocardial Infarction 41
Ultrasound-accelerated thrombolysis and extracorporeal membrane oxygenation in a patient with massive pulmonary embolism and cardiac arrest 41
Two-year cardiac mortality after MitraClip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy 41
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 41
Dual antiplatelet therapy after drug-eluting stents. How long to treat? 40
Outcomes in coronary stents trials - 1 year is not enough 40
VASCULAR COMPLICATIONS FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION WITH BOTH EDWARDS SAPIEN AND MEDTRONIC COREVALVE(R) BIOPROSTHESIS USING TRANSFEMORAL APPROACH SUPPORTED BY THE CROSS-OVER TECHNIQUE 40
Endovascular treatment of a noninfected anastomotic juxtarenal aortic aneurysm 39
Impact and evolution of right ventricular dysfunction after successful MitraClip implantation in patients with functional mitral regurgitation 39
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 39
Everolimus-eluting bioresorbable vascular scaffolds for treatment of complex chronic total occlusions 39
Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study 39
Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning 39
Subclinical Leaflet Thrombosis After Transcatheter Mitral Valve-in-Ring Implantation 39
Hypertrophic Left Ventricle With Small Cavity and Severe Aortic Angulation: A Dangerous Association in Case of Transcatheter Aortic Valve Replacement 39
Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique 38
Tricuspid annuloplasty versus a conservative approach in patients with functional tricuspid regurgitation undergoing left-sided heart valve surgery: A study-level meta-analysis 38
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 38
Observed versus predicted mortality after MitraClip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation 38
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry 37
Transcatheter Mitral Annuloplasty in Chronic Functional Mitral Regurgitation: 6-Month Results With the Cardioband Percutaneous Mitral Repair System 37
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 37
Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients 37
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study 37
Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?: A Meta-Analysis of Randomized Controlled Trials 37
FEVER AFTER TAVI (TRANSCATHETER AORTIC VALVE IMPLANTATION): IS IT INFLAMMATION OR INFECTION? 37
Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media 37
Radiation exposure and contrast agent reduction during transcatheter aortic valve implantation: An ongoing experience 37
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 37
Multimodality Imaging of a Very Late Thrombosis of a Sutureless Aortic Prosthesis 37
Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction 37
Need for permanent pacemaker implantation after corevalve, sapien and surgical aortic valve replacement: incidence, time course and predictive factors 37
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus 36
Left atrial appendage closure: A single center experience and comparison of two contemporary devices 36
Which is the best anti-aggregant or anti-coagulant therapy after TAVI? A propensity matched analysis from the ITER registry. The management of DAPT after TAVI 36
Intracoronary snaring of the retrograde guidewire: How to overcome extreme takeoff angles in chronic total occlusion percutaneous coronary intervention 36
Transcatheter Mitral Valve Replacement for Degenerated Bioprosthetic Valves and Failed Annuloplasty Rings 36
Should We Still Have Bare-Metal Stents Available in Our Catheterization Laboratory? 36
Clinical Significance of Intravascular Ultrasound-Detected Vascular Injury Following Chronic Total Occlusion Recanalization With Intraplaque Versus Subintimal Tracking Techniques 36
Totale 5.206
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 13 0 0 2 1 1 1
2021/202299 5 0 0 40 2 4 5 4 8 0 7 24
2022/2023994 408 225 87 7 6 108 30 54 29 6 15 19
2023/2024444 19 32 53 59 37 50 13 41 5 10 21 104
2024/20252.582 386 23 16 59 63 209 361 186 452 293 257 277
2025/20264.218 503 786 919 1.288 581 141 0 0 0 0 0 0
Totale 8.568